Marta Ferrer Puga-rekin lankidetzan egindako argitalpenak (43)

2022

  1. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199

  2. Consensus on the Definition of Control and Remission in Chronic Urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269

  3. Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Allergy rhinitis: Similarities and differences between children and adults

    Rhinology, Vol. 55, Núm. 4, pp. 326-331

  3. Angio-oedema without hives, IgE and omalizumab

    Clinical and Experimental Dermatology

  4. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements

    Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

  2. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis

    British Journal of Dermatology, Vol. 175, Núm. 6, pp. 1153-1165

2015

  1. Are all new allergens in TRUE Test® essential for a baseline set?

    Contact Dermatitis

  2. Management of urticaria: Not too complicated, not too simple

    Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743

  3. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema

    Annals of Allergy, Asthma and Immunology, Vol. 114, Núm. 5, pp. 418-419.e1

2014

  1. Management of angioedema without urticaria in the emergency department

    Annals of Medicine, Vol. 46, Núm. 8, pp. 607-618

2013

  1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684

  2. Antihistamines in drivers, aircrew and occupations of risk.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 27-34

  3. Bilastine for the treatment of urticaria

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544

  4. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

  5. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice

    Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228